Mimi Hou

I commenced my DPhil in the Draper Group in 2022. The aim of my project will be to isolate and characterise monoclonal antibodies against the Plasmodium vivax Duffy-binding protein. I originally joined the Draper Group in 2020 as a doctor working on the group's malaria clinical trials, testing vaccines against Plasmodium vivax and conducting controlled human malaria infection studies in healthy adult volunteers. During the pandemic, I worked on the Oxford Covid Vaccine Trials and was involved in managing the external UK sites for the phase III trial. I am a paediatric doctor by background and trainee in the Thames Valley deanery. Prior to joining the Draper group, I completed an Academic Clinical Fellowship in Oxford under Prof Rowland-Jones working on HIV evolution in infants.